Revuelta-Lopez E, Nunez J, Gastelurrutia P, Cediel G, Januzzi JL, Ibrahim NE, Emdin M, VanKimmenade R, Pascual-Figal D, Nunez E, Gommans F, Lupon J, Bayes-Genis A. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study. ESC Heart Fail. 2020 Apr;7(2):559-566. doi: 10.1002/ehf2.12607. Epub 2020 Feb 11. PubMed PMID: 32045114; PubMed Central PMCID: PMC7160502.
AÑO: 2020; IF: 4.411
|
Del Carmen Asensio Lopez M, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Oct 9;10(1):17266. doi: 10.1038/s41598-020-73065-5. PubMed PMID: 33037250; PubMed Central PMCID: PMC7547718.
AÑO: 2020; IF: 4.379
|
Fernandez-Gasso L, Hernando-Arizaleta L, Palomar-Rodriguez JA, Abellan-Perez MV, Hernandez-Vicente A, Pascual-Figal DA. Population-based Study of First Hospitalizations for Heart Failure and the Interaction Between Readmissions and Survival. Rev Esp Cardiol (Engl Ed). 2019 Sep;72(9):740-748. doi: 10.1016/j.rec.2018.08.014. Epub 2018 Sep 24. English, Spanish. PubMed PMID: 30262426.
AÑO: 2019; IF: 4.642
|
Delgado JF, Ferrero Gregori A, Fernandez LM, Claret RB, Sepulveda AG, Fernandez-Aviles F, Gonzalez-Juanatey JR, Garcia RV, Otero MR, Segovia Cubero J, Pascual Figal D, Crespo-Leiro MG, Alvarez-Garcia J, Cinca J, Ynsaurriaga FA. Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure. Curr Heart Fail Rep. 2019 Dec;16(6):304-314. doi: 10.1007/s11897-019-00442-1. PubMed PMID: 31768916.
AÑO: 2019
|
Vicent L, Cinca J, Vazquez-Garcia R, Gonzalez-Juanatey JR, Rivera M, Segovia J, Pascual-Figal D, Bover R, Worner F, Delgado-Jimenez J, Fernandez-Aviles F, Martinez-Selles M. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction. Intern Med J. 2019 Dec;49(12):1505-1513. doi: 10.1111/imj.14289. PubMed PMID: 30887642.
AÑO: 2019; IF: 1.677
|